https://ir.opthea.com/ 2025-03-07T07:31:57-05:00 daily 1.0 https://ir.opthea.com/committee-details/audit-risk 2025-07-03T11:13:49-04:00 0.5 https://ir.opthea.com/committee-details/remuneration 2025-07-03T21:56:22-04:00 0.5 https://ir.opthea.com/committee-details/nominations-governance 2025-07-03T19:53:17-04:00 0.5 https://ir.opthea.com/events/event-details/notice-annual-general-meeting-and-proxy-form 2024-10-16T22:04:22-04:00 0.5 https://ir.opthea.com/events/event-details/notice-annual-general-meeting-and-proxy-form-0 2024-10-16T22:03:41-04:00 0.5 https://ir.opthea.com/events/event-details/notice-annual-general-meeting-and-proxy-form-1 2024-10-16T22:03:05-04:00 0.5 https://ir.opthea.com/events/event-details/notice-annual-general-meeting-and-proxy-form-2 2024-10-16T22:02:23-04:00 0.5 https://ir.opthea.com/events/event-details/2017-annual-general-meeting 2024-10-16T21:55:55-04:00 0.5 https://ir.opthea.com/events/event-details/2016-annual-general-meeting 2024-10-16T21:54:10-04:00 0.5 https://ir.opthea.com/events/event-details/fireside-chat-yigal-nochomovitz-phd-director 2024-11-25T02:42:45-05:00 0.5 https://ir.opthea.com/events/event-details/opthea-present-jefferies-2023-healthcare-conference 2024-09-11T02:22:22-04:00 0.5 https://ir.opthea.com/events/event-details/ef-hutton-presentation-may-2023 2024-09-11T02:21:50-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-present-svb-securities-global-biopharma-conference-2023 2024-09-11T02:21:12-04:00 0.5 https://ir.opthea.com/events/event-details/opco-kol-forum 2023-08-21T23:19:30-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-participate-2023-euretina-congress 2024-09-11T02:16:28-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-present-jefferies-2023-london-healthcare-conference 2024-09-11T02:18:32-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-key-opinion-leader-event-sozinibercept-opt-302-wet-age-related-macular 2024-11-25T02:43:23-05:00 0.5 https://ir.opthea.com/events/event-details/opthea-participate-23r-annual-needham-virtual-healthcare-conference 2024-09-11T02:25:54-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-present-ois-retina-innovation-summit-arvo 2024-09-11T02:26:25-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-present-retina-world-congress-2024 2024-09-11T02:28:46-04:00 0.5 https://ir.opthea.com/events/event-details/opthea-present-clinical-trials-summit-meeting 2024-09-11T02:29:17-04:00 0.5 https://ir.opthea.com/events/event-details/jefferies-global-healthcare-conference 2024-06-04T18:22:31-04:00 0.5 https://ir.opthea.com/events/event-details/hc-wainwright-4th-annual-ophthalmology-virtual-conference 2024-08-08T22:36:32-04:00 0.5 https://ir.opthea.com/events/event-details/hc-wainwright-26th-annual-global-investment-conference 2024-09-24T18:05:01-04:00 0.5 https://ir.opthea.com/events/event-details/cantor-2024-global-healthcare-conference 2024-09-04T05:15:57-04:00 0.5 https://ir.opthea.com/events/event-details/euretina-innovation-spotlight-eis 2024-09-11T02:13:36-04:00 0.5 https://ir.opthea.com/events/event-details/24th-euretina-congres 2024-09-11T02:14:49-04:00 0.5 https://ir.opthea.com/events/event-details/ubs-virtual-ophthalmology-day-2024 2024-10-02T02:53:40-04:00 0.5 https://ir.opthea.com/events/event-details/2024-annual-general-meeting 2024-10-16T21:52:47-04:00 0.5 https://ir.opthea.com/events/event-details/2022-annual-general-meeting 2024-10-16T22:05:56-04:00 0.5 https://ir.opthea.com/events/event-details/2023-annual-general-meeting 2024-10-16T22:07:41-04:00 0.5 https://ir.opthea.com/events/event-details/bell-potter-healthcare-conference 2024-11-03T21:38:32-05:00 0.5 https://ir.opthea.com/events/event-details/jefferies-london-healthcare-conference-2024 2024-11-03T21:39:29-05:00 0.5 https://ir.opthea.com/events/event-details/citi-2024-global-healthcare-conference 2024-11-25T11:56:03-05:00 0.5 https://ir.opthea.com/events/event-details/43rd-annual-jp-morgan-healthcare-conference 2025-01-07T18:26:07-05:00 0.5 https://ir.opthea.com/events/event-details/opthea-investor-day 2025-01-28T16:42:01-05:00 0.5 https://ir.opthea.com/events/event-details/opthea-investor-day-0 2025-01-08T13:50:50-05:00 0.5 https://ir.opthea.com/events/event-details/opthea-investor-day-1 2025-01-08T13:50:00-05:00 0.5 https://ir.opthea.com/events/event-details/oppenheimers-35th-annual-healthcare-life-sciences-conference 2025-02-26T14:11:16-05:00 0.5 https://ir.opthea.com/events/event-details/opthea-virtual-business-update 2025-08-18T18:58:06-04:00 0.5 https://ir.opthea.com/events/event-details/2025-annual-general-meeting 2025-09-17T07:25:19-04:00 0.5 https://ir.opthea.com/investor-relations 2025-03-07T07:31:57-05:00 0.8 https://ir.opthea.com/press-releases 2025-10-30T18:39:08-04:00 0.8 https://ir.opthea.com/presentations-events 2025-02-26T11:29:42-05:00 0.8 https://ir.opthea.com/corporate-governance 2025-07-03T19:54:57-04:00 0.8 https://ir.opthea.com/stock-information 2025-02-24T10:57:37-05:00 0.8 https://ir.opthea.com/investor-resources 2025-09-29T10:33:59-04:00 0.8 https://ir.opthea.com/filings 2025-03-19T08:22:39-04:00 0.8 https://ir.opthea.com/eyewiretv 2023-01-23T13:17:22-05:00 0.4 https://ir.opthea.com/clinical-trial-download-data-phase-2b-trial-opt-302 2023-01-23T13:16:57-05:00 0.4 https://ir.opthea.com/eyeworld-onsite 2023-01-23T13:18:55-05:00 0.4 https://ir.opthea.com/ophthalmology-advisor 2023-06-22T15:02:59-04:00 0.4 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-san-francisco-jan-2023 2023-06-11T19:25:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-mst-conference-call-jason-slakter-md 2023-06-21T22:04:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-floretina-2022-congress 2023-06-20T23:48:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice 2023-06-13T12:21:46-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a 2023-06-13T12:22:12-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-0 2023-06-13T12:09:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-0 2023-06-13T12:10:45-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3y-ms 2023-06-13T12:11:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3y-mb 2023-06-13T12:02:42-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt 2023-06-13T12:12:26-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-0 2023-06-13T12:13:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-1 2023-06-13T12:12:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting 2023-06-13T12:12:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/chairmans-address-shareholders 2023-06-13T12:11:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-jefferies-london-healthcare-conference 2023-06-13T12:21:12-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-1 2023-06-13T12:14:42-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-1 2023-06-13T12:15:00-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-expands-leadership-team-cfo-appointment 2023-06-12T19:18:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-general-meetingproxy-form 2023-06-12T19:19:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding 2023-06-12T19:19:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-0 2023-06-12T19:19:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-2 2023-06-12T19:20:11-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt 2023-06-12T19:20:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-0 2023-06-12T19:21:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-0 2023-06-12T19:21:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/completion-share-purchase-plan 2023-06-12T19:21:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4g-corporate-governance-statement-2022 2023-06-12T19:22:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-fiscal-year-2022-results-and-highlights 2023-06-20T19:39:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4e-and-annual-report-2022 2023-06-12T19:22:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-1 2023-06-12T19:22:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-2 2023-06-12T19:22:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-3 2023-06-12T19:23:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-share-purchase-plan 2023-06-12T19:23:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-3 2023-06-12T19:23:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/update-application-quotation-securities-opt 2023-06-12T19:24:54-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-1 2023-06-12T19:24:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-extraordinary-general-meetingproxy-form 2023-06-12T19:33:26-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-hc-wainwright-2nd-annual-conference 2023-06-12T19:27:07-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/form-6-k-sec 2023-06-12T19:27:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-successfully-closes-well-supported-us90m-financing 2023-06-20T19:33:54-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt 2023-06-12T19:27:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt-0 2023-06-12T19:27:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-secures-us170m-non-dilutive-financing 2023-06-12T19:27:40-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt 2023-06-12T19:28:57-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-2 2023-06-12T19:29:10-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-3 2023-06-12T19:29:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-4 2023-06-12T19:29:03-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder 2023-06-12T19:30:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder 2023-06-12T19:30:09-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-4 2023-06-12T19:30:16-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-4 2023-06-12T19:30:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-2 2023-06-12T19:30:52-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-0 2023-06-12T19:31:09-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-5 2023-06-12T19:31:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-6 2023-06-12T19:31:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-upcoming-investor-conferences 2023-06-20T19:26:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presentation-retina-world-congress-2022 2023-06-20T19:25:07-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-data-opt-302-pcv-presented-arvo-2022 2023-06-20T19:20:18-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-7 2023-06-12T19:35:26-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presenting-clinical-data-arvo-2022-annual-meeting 2023-06-20T19:23:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-8 2023-06-12T19:36:45-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-9 2023-06-12T19:36:51-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-qo 2023-06-12T19:37:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-so 2023-06-12T19:37:12-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-strengthens-its-board-directors 2023-06-20T19:16:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-1 2023-06-12T19:37:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-1 2023-06-12T19:37:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-10 2023-06-12T19:38:04-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-11 2023-06-12T19:38:10-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-12 2023-06-12T19:39:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-13 2023-06-12T19:39:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-14 2023-06-12T19:39:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-15 2023-06-12T19:39:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-16 2023-06-12T19:39:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-17 2023-06-12T19:41:04-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-general-meeting-and-proxy-form 2023-06-12T19:40:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-18 2023-06-12T19:41:24-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-19 2023-06-12T19:41:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-oppenheimers-32nd-healthcare-conference 2023-06-20T19:16:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-20 2023-06-12T19:41:41-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-21 2023-06-12T19:41:54-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/sp-dji-announces-march-2022-quarterly-rebalance 2023-06-12T19:51:40-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-drjoel-naor-md-chief-medical-officer 2023-06-21T21:57:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-22 2023-06-12T19:51:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-report-and-accounts 2023-08-03T04:34:11-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-23 2023-06-12T19:53:45-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-24 2023-06-12T19:53:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-0 2023-06-12T19:54:08-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-25 2023-06-12T19:54:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/angiogenesis-2022-prof-cheung-presentation-pcv-data 2023-06-20T02:58:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-data-opt-302-patients-pvc-presented 2023-06-20T02:57:07-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-svb-leerink-global-healthcare-conference 2023-06-21T21:59:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-angiogenesis-2022-conference 2023-06-21T22:00:23-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-26 2023-06-12T19:55:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-27 2023-06-12T19:55:19-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-28 2023-06-12T19:56:09-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-29 2023-06-12T19:56:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-establishment-atm-equity-program 2023-06-21T22:01:24-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/form-f-3-registration-statement 2023-06-12T19:56:40-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-1 2023-06-12T19:57:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-2 2023-06-13T12:03:51-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-2 2023-06-12T19:58:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-3 2023-06-12T19:58:08-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a66m-rd-tax-incentive 2023-06-20T02:49:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-3 2023-06-12T19:58:27-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-4 2023-01-25T05:54:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-30 2023-01-25T05:55:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-4 2023-01-25T05:55:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-hc-wainwright-bioconnect-conference 2023-06-20T02:48:04-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-cco-lead-commercialization-opt-302 2023-06-20T02:46:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-5 2023-01-25T06:00:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-5 2023-01-25T06:01:04-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-6 2023-01-25T06:01:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-3 2023-01-25T06:03:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-5 2023-01-25T06:03:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-31 2023-01-25T06:04:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-5 2023-01-25T06:05:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb 2023-01-25T06:06:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-6 2023-06-13T12:13:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-jh 2023-01-25T06:08:34-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-jr 2023-01-25T06:09:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-7 2023-01-25T06:10:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-32 2023-01-25T07:38:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-33 2023-01-25T07:39:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-34 2023-01-25T07:42:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-4 2023-01-25T07:46:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-6 2023-01-25T07:48:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-granted-chinese-patent-covering-opt-302 2023-06-20T02:43:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-35 2023-01-25T07:51:02-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-6 2023-01-25T07:52:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-update 2023-01-25T07:54:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-update 2023-01-25T07:56:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-7 2023-01-25T11:28:02-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-5 2023-01-25T11:29:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-opens-patient-enrollment-asia-pacifi-region 2023-06-21T22:05:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-2 2023-01-25T11:47:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-october-2021 2023-01-25T11:48:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-chairmans-address-2021-annual-general-meeting 2023-01-25T11:50:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-7 2023-01-25T11:52:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-phase-3-open-patient-recruitment-europe 2023-06-20T02:39:23-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-36 2023-01-25T11:56:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-8 2023-01-25T11:58:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-7 2023-01-25T12:42:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/addendum-notice-meeting 2023-01-25T12:43:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/addendum-notice-meeting-0 2023-02-12T18:53:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form 2023-01-25T12:45:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4g-corporate-governance-statement-amended 2023-01-25T12:45:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-september-investor-conferences 2023-06-20T02:37:12-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4g-corporate-governance-statement 2023-01-25T12:48:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-fiscal-year-2021-results-and-highlights 2023-06-20T02:35:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4e-and-annual-report 2023-02-12T18:31:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-8 2023-02-12T18:37:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-9 2023-01-25T12:56:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-10 2023-01-26T04:34:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-9 2023-06-12T20:08:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-11 2023-01-26T04:37:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-10 2023-01-26T04:38:34-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-hc-wainwright-ophthalmology-conference 2023-06-20T02:18:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-expands-phase-3-opt-302-canada 2023-06-20T02:16:07-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-12 2023-01-26T04:41:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-opt-302-granted-fast-track-wet-amd 2023-06-20T02:14:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-37 2023-01-26T04:43:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-38 2023-01-26T04:44:13-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-8 2023-01-26T04:45:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-2 2023-01-26T04:45:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-39 2023-01-26T04:46:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-40 2023-01-26T04:47:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt-1 2023-01-26T04:48:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-company-secretary-and-vp-finance 2023-06-20T02:10:57-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-jh 2023-01-26T04:51:12-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-jr 2023-01-26T08:46:44-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/director-appointmentresignation 2023-06-20T02:05:46-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-41 2023-01-26T08:56:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-11 2023-01-26T08:57:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-company-secretary-resignation 2023-06-20T02:03:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-fda-waiver-pediatric-study-plan 2023-06-20T02:01:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-42 2023-01-26T09:10:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-update-0 2023-01-26T09:11:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-9 2023-01-26T09:12:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-6 2023-01-26T09:12:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt-2 2023-01-26T09:13:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-treats-first-patient-phase-3-trials-opt-302 2023-06-20T01:59:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-oppenheimer-healthcare-conference 2023-06-20T01:57:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-ms 2023-01-26T11:02:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-0 2023-01-26T11:03:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-lg 2023-01-26T11:04:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-jl 2023-01-26T11:05:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-ds 2023-01-26T11:06:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-7 2023-01-26T11:06:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3g 2023-01-26T11:08:18-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-finalizes-ph-3-study-designs-and-startup-activities 2023-06-20T01:55:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-report-and-accounts-0 2023-01-26T11:10:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-43 2023-01-26T11:11:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-svb-leerink-healthcare-conference 2023-06-20T01:26:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-44 2023-01-26T11:13:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-45 2023-01-26T11:14:13-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-12 2023-01-26T11:14:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-3 2023-01-26T11:16:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-13 2023-01-26T11:17:33-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-13 2023-01-26T11:19:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-general-meeting-and-proxy-form-0 2023-01-26T11:20:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-14 2023-01-26T11:22:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-46 2023-01-26T11:23:42-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-47 2023-01-26T11:24:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-14 2023-01-26T11:25:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-15 2023-01-26T11:26:13-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-48 2023-01-26T11:26:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-49 2023-01-26T11:28:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-50 2023-01-26T11:29:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-51 2023-01-26T11:30:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-52 2023-01-26T11:31:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-53 2023-01-26T11:32:25-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-54 2023-01-26T11:33:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-55 2023-01-26T11:34:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-56 2023-01-26T11:35:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a85m-rd-tax-incentive 2023-06-20T01:25:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-gk 2023-01-26T11:36:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-15 2023-01-26T11:37:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-57 2023-01-26T11:39:04-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-16 2023-01-26T11:40:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-16 2023-01-26T11:40:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-closing-us-initial-public-offering 2023-01-26T11:41:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-58 2023-01-26T11:42:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-10 2023-01-26T11:43:11-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-8 2023-01-26T11:44:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt-3 2023-01-26T11:49:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-pricing-us-initial-public-offering 2023-01-26T11:51:13-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-0 2023-01-26T11:52:37-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-jl 2023-01-26T11:53:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-17 2023-01-26T11:54:14-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-launches-proposed-us-initial-public-offering 2023-06-20T01:11:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-4 2023-01-26T11:55:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-1 2023-01-26T11:56:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-chairman-address-2020-annual-general-meeting 2023-01-26T11:57:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoint-dr-jeremy-levin-chairman-board 2023-06-20T00:56:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-17 2023-01-26T11:59:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-files-registration-statement-proposed-us-ipo 2023-06-20T00:53:19-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-59 2023-01-26T12:00:54-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-60 2023-01-26T12:02:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-ds 2023-01-26T13:16:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form-0 2023-01-26T13:17:09-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4g-and-corporate-governance-statement-2020 2023-01-26T13:17:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/annual-report-2020 2023-01-26T13:19:04-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-us-based-non-executive-director 2023-01-26T13:19:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-full-year-financial-report-2020 2023-01-26T13:20:36-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-plans-potential-us-listing-and-ipo 2023-01-26T13:21:23-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-successful-fda-and-ema-meetings-phase-3 2023-01-26T13:22:12-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-key-opinion-leader-symposium-presentation 2023-01-26T13:23:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-key-opinion-leader-symposium-wamd-and-dme 2023-06-20T00:47:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-lg 2023-01-26T13:24:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/corporate-presentation-ph1b2a-dme-trial-data-asrs 2023-06-21T22:06:46-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-new-data-ph-1b2a-dme-trial-asrs 2023-06-20T00:42:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-new-non-executive-director 2023-01-26T13:26:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-opt-302-dme-clinical-data-asrs-2020 2023-06-20T00:38:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-61 2023-01-26T13:28:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-62 2023-01-26T13:29:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-added-spasx-300-index 2023-01-26T13:30:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/sp-dji-announces-june-2020-quarterly-rebalance 2023-01-26T13:31:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-positive-ph2a-trial-results-opt-302-dme 2023-06-20T00:23:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-investor-teleconference 2023-06-20T00:10:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-2 2023-01-26T13:34:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-63 2023-01-26T13:35:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-64 2023-01-26T13:36:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-65 2023-01-26T13:37:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-18 2023-01-26T13:37:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-patient-dosing-phase-2a-dme-trial 2023-06-20T00:02:23-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-mufg 2023-01-26T13:39:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-ms 2023-01-26T13:40:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-mufg 2023-01-26T13:41:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-ms 2023-01-26T13:41:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-18 2023-01-26T13:42:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-66 2023-01-26T13:43:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-19 2023-01-26T13:44:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-report-and-accounts-1 2023-01-26T13:45:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-svb-leerink-healthcare-conference-0 2023-06-21T22:10:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-19 2023-01-26T13:48:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-20 2023-01-26T13:50:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-recruitment-ph2a-trial-opt-302-dme 2023-06-19T23:54:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-20 2023-01-26T13:55:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-21 2023-01-26T13:56:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-67 2023-01-26T13:59:38-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-21 2023-01-26T14:00:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/completion-a50-million-institutional-placement 2023-01-27T02:32:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-22 2023-01-27T02:34:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b 2023-01-27T02:35:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-equity-raising-presentation 2023-01-27T02:38:51-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-raises-a50-million-institutional-placement 2023-06-19T23:48:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-22 2023-01-27T02:53:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-23 2023-01-27T02:54:42-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-23 2023-01-27T05:25:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-5 2023-01-27T05:29:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ceo-presentation-2019-agm 2023-01-27T05:33:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-chairman-address-2019-agm 2023-01-27T05:34:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-68 2023-01-27T05:36:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-24 2023-01-27T05:54:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-clinical-data-published-leading-ophthalmic-journal 2023-01-27T05:40:44-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-24 2023-01-27T05:42:23-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form-1 2023-01-27T05:47:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4g-and-corporate-governance-statement-2019 2023-02-12T19:09:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/annual-report-2019 2023-01-27T05:49:42-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presentation-ophthalmology-innovation-summit 2023-06-21T22:12:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-additional-data-ph2b-trial-ois-us 2023-01-27T05:52:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-69 2023-01-27T05:53:11-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-25 2023-01-27T05:56:08-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-25 2023-01-27T05:56:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-ophthalmology-innovation-summit-us 2023-06-19T22:55:35-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a146m-rd-tax-incentive 2023-06-19T20:08:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-0 2023-01-27T06:04:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-70 2023-01-27T06:05:36-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presentation-euretina-congress 2023-06-21T22:13:27-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-positive-phase-2b-data-euretina-congress 2023-06-19T20:04:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ph2b-opt-302-wamd-be-presented-euretina 2023-01-27T06:08:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-71 2023-01-27T06:09:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-72 2023-01-27T06:10:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-73 2023-01-27T06:11:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-74 2023-01-27T06:12:12-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-26 2023-01-27T06:13:01-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-75 2023-01-27T06:14:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-1 2023-01-27T06:15:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/preliminary-final-report 2023-01-27T06:17:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-meets-primary-endpoint-phase-2b-study-opt-302 2023-06-19T19:58:11-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-investor-teleconference-0 2023-01-27T06:18:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-3 2023-01-27T06:19:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-european-patent-application-be-granted 2023-06-19T19:44:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-provides-timing-update-opt-302-clinical-trials 2023-01-27T06:21:33-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-76 2023-01-27T06:22:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-final-patient-visit-phase-2b-wamd-trial 2023-06-19T19:40:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-2 2023-01-27T06:24:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-1 2023-01-27T06:25:19-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-ms-0 2023-01-27T06:26:14-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-gk 2023-01-27T06:27:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-2 2023-01-27T06:28:23-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-3 2023-01-27T06:29:18-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-added-spasx-all-ordinaries-index 2023-01-27T06:30:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/sp-dji-announces-march-2019-quarterly-rebalance 2023-01-27T06:30:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ph2b-trial-advances-2nd-positive-safety-review 2023-01-27T06:31:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-report-and-accounts-2 2023-01-27T06:33:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-granted-japanese-patent-covering-opt-302 2023-06-19T19:37:45-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-sequire-biotechnology-conference 2023-01-30T06:01:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-27 2023-02-01T02:40:33-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-28 2023-02-01T02:41:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-gk-0 2023-02-01T02:42:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-3 2023-02-01T02:43:19-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-4 2023-02-01T02:44:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-77 2023-02-01T02:45:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-6 2023-02-01T02:45:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ceo-presentation-2018-agm 2023-02-01T02:47:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-chairman-address-2018-agm 2023-02-01T02:48:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-5 2023-02-01T02:48:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-options-exercise-generates-proceeds-a133m 2023-02-01T02:49:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-confirms-final-patient-enrolment-ph2b-wamd-trial 2023-02-01T02:51:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-6 2023-02-01T02:52:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-7 2023-02-01T02:53:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-78 2023-02-01T02:55:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-phase-2b-wamd-trial-fully-recruited-ahead-schedule 2023-02-01T04:27:13-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-8 2023-02-01T04:28:23-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-9 2023-02-01T04:29:33-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-79 2023-02-01T04:30:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-10 2023-02-01T04:32:04-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a12m-rd-tax-incentive 2023-02-01T04:56:18-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/letter-option-holders 2023-02-01T04:57:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-provides-update-key-opinion-leader-forum 2023-02-01T04:58:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form-2 2023-02-01T05:00:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form-3 2023-02-01T05:14:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ceo-presentation-trial-updates-oisaao-2018 2023-02-01T05:22:25-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-positive-data-ph1b-dme-study-opt-302 2023-02-01T05:23:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-ophthalmology-innovation-summit 2023-02-01T05:24:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-11 2023-02-01T05:26:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-12 2023-02-01T05:44:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-13 2023-02-01T05:45:19-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-80 2023-02-01T05:56:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-wamd-and-dme-key-opinion-leader-forum 2023-02-01T05:57:19-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-14 2023-02-01T05:58:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-doses-first-patients-australia-phase-2a-dme 2023-02-01T05:59:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-ph12a-wamd-data-retina-society-meeting 2023-02-01T06:00:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-positive-safety-review-ph2b-wamd-trial 2023-02-01T06:01:11-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4g-and-corporate-governance-statement-2018 2023-02-01T06:02:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4e-and-annual-report-2018 2023-02-01T06:03:54-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-15 2023-02-01T06:05:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-doses-first-patient-ph2a-trial-opt-302-dme 2023-02-01T11:34:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-meets-primary-safety-objective-dme-phase-1b-trial 2023-02-01T11:36:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reaches-mid-way-recruitment-ph2b-wamd-trial 2023-02-01T11:37:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-16 2023-02-01T11:39:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-81 2023-02-01T11:41:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-anp 2023-02-01T11:43:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-doses-wamd-patients-europe-and-israel 2023-02-01T11:45:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-report-and-accounts-3 2023-02-01T11:49:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-17 2023-02-01T11:51:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-january-2018 2023-02-01T11:52:58-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a27m-rd-tax-incentive 2023-02-01T11:54:27-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-initiates-opt-302-diabetic-macular-edema-trial 2023-02-01T11:55:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-82 2023-02-01T12:31:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-full-copy 2023-02-01T12:34:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-doses-first-patient-opt-302-wamd-ph2b-trial 2023-02-01T12:35:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-83 2023-02-01T12:36:48-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-18 2023-02-01T12:37:36-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-7 2023-02-01T12:38:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ceo-presentation-2017-agm 2023-02-01T12:39:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-chairmans-address-2017-agm 2023-02-01T12:41:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-19 2023-02-01T12:43:09-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form-4 2023-02-01T12:44:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-granted-key-united-states-patent-covering-opt-302 2023-02-01T12:45:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4g-and-corporate-governance-statement-2017 2023-02-01T12:47:02-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4e-and-annual-report-2017 2023-02-01T12:48:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-further-positive-data-opt-302-ph12a 2023-02-01T12:49:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presentation-ophthalmology-innovation-summit-0 2023-02-01T12:50:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-ophthalmology-innovation-summit 2023-02-01T12:52:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-asrs-annual-meeting-and-ois 2023-02-01T12:54:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-wedbush-pacgrow-conference 2023-02-01T12:55:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-allowed-key-patent-opt-302-united-states 2023-02-01T12:57:09-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-20 2023-02-01T13:00:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-gk-1 2023-02-02T04:29:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-4 2023-02-02T04:30:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-21 2023-02-02T04:30:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-a45-million-capital-raising 2023-02-02T04:31:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-ms-1 2023-02-02T04:32:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-26 2023-02-02T04:33:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-84 2023-02-02T04:34:08-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/placement-cleansing-statement 2023-02-02T04:35:03-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-22 2023-02-02T04:35:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-entitlement-offer-notice-ineligible-shareholders 2023-02-02T04:36:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-retail-entitlement-offer-booklet 2023-02-02T04:37:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/asx-notice-accelerated-non-renounceable-entitlement-offer 2023-02-02T04:38:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-successfully-completes-institutional-capital-raising 2023-02-02T04:39:14-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/entitlement-offer-cleansing-statement 2023-02-02T04:40:01-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-23 2023-02-02T04:40:51-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-a45m-equity-raising-launch-presentation 2023-02-02T04:41:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-launches-a45m-financing-clinical-development 2023-02-02T04:42:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-phase-12a-wet-amd-trial-update-presentation 2023-02-02T04:43:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-positive-phase-12a-clinical-results 2023-02-02T04:43:54-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-4 2023-02-02T04:44:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-update-opt-302-phase-12a-wamd-trial 2023-02-02T04:50:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-5 2023-02-02T04:51:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-eu-regulatory-feedback-opt-302-program 2023-02-02T04:53:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-27 2023-02-02T04:54:09-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-fda-meeting-inform-opt-302-program 2023-02-02T04:54:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-report-and-accounts-4 2023-02-02T04:55:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-85 2023-02-02T04:56:36-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-24 2023-02-02T04:57:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-during-jpmorgan-conference 2023-02-02T05:04:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-8 2023-02-02T05:23:02-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ceo-presentation-2016-agm 2023-02-02T05:23:51-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-chairmans-address-2016-agm 2023-02-02T05:24:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-patient-enrolment-ph12a-wamd-trial 2023-02-02T05:25:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meeting-and-proxy-form-5 2023-02-02T05:26:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-26m-rd-tax-incentive 2023-02-02T05:27:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-25 2023-02-02T05:28:02-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ph1-wamd-data-presented-euretina-2016 2023-02-02T05:28:51-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4g-and-corporate-governance-statement-2016 2023-02-02T05:29:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4e-and-annual-report-2016 2023-02-02T05:30:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-ophthalmology-innovation-summit-us-0 2023-02-02T05:31:23-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-positive-data-phase-1-wet-amd-trial 2023-02-02T05:32:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-conference-call-update-wetamd-trial 2023-02-02T05:37:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-5 2023-02-02T05:38:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3b-26 2023-02-02T05:38:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-anp 2023-02-02T05:39:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-doses-first-patient-ph2a-opt-302-wet-amd 2023-02-02T05:40:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ph1-wamd-trial-opt-302-meets-primary-objective 2023-02-02T05:41:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-gk-2 2023-02-02T05:42:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-ms-2 2023-02-02T05:42:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-6 2023-02-02T05:43:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-patient-enrolment-phase-1-wet-amd-trial 2023-02-02T05:44:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-extraordinary-general-meeting 2023-02-02T05:45:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceos-presentation-egm 2023-02-02T05:46:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/chairmans-address-egm 2023-02-02T05:47:23-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/half-year-report-and-accounts 2023-02-02T05:48:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-extraordinary-general-meetingproxy-form-0 2023-02-02T05:49:04-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-29 2023-02-02T05:50:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-svb-leerink-global-biopharma-conference 2023-02-06T06:00:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-28 2023-06-12T19:57:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-8 2023-02-12T18:50:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-30 2023-02-12T19:06:48-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-phase-2b-trial-results-opt-302-combination-lucentisr-wet 2023-02-13T06:00:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-fireside-chat-oppenheimers-33rd-annual 2023-03-06T06:01:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a87-million-rd-tax-incentive 2023-03-07T06:01:18-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-hc-wainwright-bioconnect-conference-nasdaq 2023-04-28T05:30:52-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-jmp-securities-life-sciences-conference 2023-05-08T05:31:01-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-ef-hutton-hosted-discussion-opt-302-and-wet 2023-05-17T06:00:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-jefferies-2023-healthcare-conference 2023-05-25T06:00:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-86 2023-06-08T20:52:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-29 2023-06-11T19:33:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-31 2023-06-11T19:30:42-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/half-year-accounts 2023-06-11T19:30:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/response-asx-query 2023-06-11T19:29:52-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-9 2023-06-11T19:29:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-anshul-thakral-non-executive-director-board 2023-06-08T06:01:20-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-ms 2023-06-11T19:34:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice 2023-06-11T19:33:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-anshul-thakral-non-executive-director 2023-06-11T19:33:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-jefferies-2023-healthcare-conference 2023-06-11T19:33:00-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participates-ef-hutton-hosted-webinar-opt-302 2023-06-11T19:32:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-jmp-securities-life-sciences-conference 2023-06-11T19:32:46-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-hc-wainwright-bioconnect-conference 2023-06-08T20:55:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a87million-rd-tax-incentive 2023-06-11T19:30:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-oppenheimers-healthcare-conference 2023-06-11T19:30:30-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-ph2b-trial-results-opt-302-published-journal 2023-06-11T19:29:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-svb-leerink-global-biopharma-conference-0 2023-06-11T19:29:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-sequire-biotechnology-conference-0 2023-06-11T19:29:03-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-11 2023-06-11T20:58:16-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-10 2023-06-11T20:59:45-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-11 2023-06-11T21:00:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-12 2023-06-11T21:01:40-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3y-ms-0 2023-06-11T21:02:30-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-3y-mb-0 2023-06-11T21:03:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-9 2023-06-11T21:04:27-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-10 2023-06-11T21:05:37-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-11 2023-06-11T21:06:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-9 2023-06-13T12:08:48-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/chairmans-address-shareholders-0 2023-06-20T23:45:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-jefferies-london-healthcare-conference-0 2023-06-11T21:10:11-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-12 2023-06-12T19:16:19-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/cleansing-notice-13 2023-06-12T19:17:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-jefferies-london-healthcare-conference-1 2023-06-20T22:54:42-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-expands-leadership-team-appointment-timothy-e-morris 2023-06-20T22:53:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-presentation-hc-wainwright-2nd-annual 2023-06-20T19:37:11-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-secures-us170-million-non-dilutive-financing-opt-302-wet 2023-06-20T19:30:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-phase-2b-trial-wet-amd-advances-second-positive 2023-06-19T19:33:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-87 2023-06-23T02:56:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-departure-chief-medical-officer-and-appointment 2023-07-10T06:00:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-appointment-snr-medical-advisor 2023-07-10T18:34:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-feature-american-society-retina-specialists-2023-annual 2023-08-02T05:22:24-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-feature-asrs-2023-annual-meeting 2023-07-13T18:26:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-2023-ophthalmology-innovation-summit 2023-07-24T06:00:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-2023-ophthalmology-innovation-summit 2023-07-24T18:21:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-sozinibercept-nonproprietary-drug-name-opt-302 2023-07-26T06:00:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opt-announces-sozinibercept-drug-name-opt-302 2023-07-26T18:16:04-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/asrs-2023-pk-and-safety-sozinibercept-opt-302 2023-07-31T19:36:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-32 2023-08-02T18:31:03-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-30 2023-08-09T03:41:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-33 2023-08-11T04:56:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-31 2023-08-20T18:08:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-a80m-capital-raise 2023-08-23T20:06:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-6 2023-08-23T20:34:18-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/prospectus 2023-08-23T20:42:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-investor-presentation 2023-08-23T20:45:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt-4 2023-08-23T21:31:09-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/update-proposed-issue-securities-opt 2023-08-23T22:31:16-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-institutional-offer-and-increases-raise 2023-08-27T20:26:57-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/update-proposed-issue-securities-opt-0 2023-08-27T20:28:37-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-successfully-completes-institutional-offer-and-increases 2023-08-28T05:30:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/preliminary-final-report-0 2023-08-30T19:20:12-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-retail-entitlement-offer-opens 2023-08-30T19:26:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-3 2023-08-31T20:55:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-34 2023-09-03T18:14:48-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-32 2023-09-05T18:32:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-88 2023-09-05T18:33:57-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-33 2023-09-06T03:46:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-hc-wainwright-25th-annual-global-investment 2023-09-07T05:30:26-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-hcwainwright-25th-investment-conference 2023-09-07T18:23:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/security-class-suspension-quotation-optoa 2023-09-14T18:31:54-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-completion-retail-entitlement-offer 2023-09-20T18:30:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-13 2023-09-20T21:36:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optoa-range-units 2023-09-20T21:45:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optoa-top-holders 2023-09-20T21:46:08-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-2a-update-1 2023-09-20T22:47:55-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/security-class-reinstatement-quotation-optoa 2023-09-21T18:46:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-89 2023-09-25T02:51:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-fy-2023-annual-report-shareholders 2023-09-27T18:51:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appendix-4g-corporate-governance 2023-09-27T19:07:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-2023-euretina-congress 2023-10-02T05:30:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-2023-euretina-congress-0 2023-10-02T17:16:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-4 2023-10-12T20:06:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-7 2023-10-24T18:35:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-us-based-leadership 2023-10-26T19:43:18-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meetingproxy-form 2023-10-26T19:51:08-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-us-based-leadership-fred-guerard-ceo-and-peter 2023-10-27T05:30:19-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-eyecelerator-forum-2023-american-academy 2023-10-30T05:30:30-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-eyecelerator-aao 2023-10-30T17:09:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-jefferies-2023-london-healthcare-conference 2023-11-09T05:30:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-jefferies-2023-healthcare-conference-0 2023-11-09T16:24:13-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/2023-agm-chairmans-address 2023-11-29T17:21:11-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-10 2023-11-29T20:20:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-floretina-2023-congress 2023-11-30T16:15:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-floretina-2023-congress-0 2023-12-01T05:30:26-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a88-million-rd-tax-incentive 2023-12-19T06:00:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a88-million-rd-tax-incentive-0 2023-12-19T16:37:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-12 2023-12-20T16:51:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-12 2023-12-20T16:51:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-13 2023-12-20T16:51:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice 2023-12-20T16:56:19-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-mb-7 2023-12-20T16:56:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-lg-0 2023-12-20T17:37:49-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-jl-0 2023-12-20T17:43:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receive-us35m-commitment-and-additional-us50m 2023-12-26T16:32:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receive-us35m-commitment-and-additional-us50m-funding 2023-12-27T06:00:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-strengthens-team-key-clinical-and-regulatory-hires 2024-02-01T06:00:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-strengthens-team-key-clinical-regulatory-hires 2024-02-01T16:28:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-enrollment-first-pivotal-trial-sozinibercept 2024-02-14T07:00:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-enrollment-first-trial-sozinibercept 2024-02-14T16:44:52-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-arshard-m-khanani-chief-medical-advisor 2024-02-19T17:10:55-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-arshad-m-khanani-md-ma-fasrs-chief-medical 2024-02-19T18:26:14-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-half-year-results-and-business-update 2024-02-28T17:11:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/half-yearly-report-and-accounts 2024-02-28T17:12:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-half-year-financial-results-and-business-updates 2024-02-28T17:57:06-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-0 2024-02-29T17:55:22-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-update 2024-02-29T18:25:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-march-2024 2024-03-03T19:58:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-leerink-global-biopharma-conference 2024-03-05T16:33:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-leerink-partners-global-biopharma-conference 2024-03-05T17:08:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-key-opinion-leader-event-sozinibercept-opt-302-wet 2024-03-19T06:00:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-key-opinion-leader-event-april-3-2024 2024-04-03T00:07:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-14 2024-04-03T00:07:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-sujal-shah-board-directors 2024-04-03T17:40:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-sujal-shah-board-directors-0 2024-04-03T17:42:03-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-key-opinion-leader-even-sozinibercept 2024-04-03T17:42:23-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-sujal-shah 2024-04-03T18:23:18-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-ds 2024-04-03T18:35:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opteha-participate-23rd-needham-virtual-conference 2024-04-04T18:15:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-23r-annual-needham-virtual-healthcare 2024-04-04T18:34:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-april-2024 2024-04-04T18:35:24-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-john-han-pharmd-vp-medical-affairs 2024-04-08T18:26:06-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-john-han-pharmd-vp-medical-affairs-0 2024-04-08T18:42:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-15 2024-04-14T21:00:23-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-16 2024-04-14T21:25:00-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-ois-retina-innovation-summit-arvo 2024-04-25T09:00:37-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-ois-retina-innovation-summit-arvo 2024-04-25T18:22:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report 2024-04-29T18:30:20-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-presentations-retina-world-congress 2024-04-30T19:50:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-upcoming-presentations-retina-world-congress 2024-05-01T07:30:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-enrollment-phase-3-clinical-program 2024-05-27T18:40:00-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-enrollment-pivotal-phase-3-clinical-program 2024-05-28T07:30:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-clinical-trials-summit-meeting 2024-06-02T19:05:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-clinical-trials-summit-meeting-0 2024-06-03T07:30:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-8 2024-06-06T18:59:48-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-accelerated-offer 2024-06-11T19:35:16-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-annouces-equity-raise 2024-06-11T19:46:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-equity-raise-investor-presentation 2024-06-11T19:46:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-placement-and-partially-underwritten 2024-06-11T21:14:08-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-prospectus-2024 2024-06-11T21:30:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/proposed-issue-securities-opt-5 2024-06-11T21:44:52-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/update-proposed-issue-securities-opt-1 2024-06-12T02:11:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-placement-institutional-entitlement-offer 2024-06-13T18:55:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-successfully-completes-placement-and-institutional 2024-06-13T19:58:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-a550m-us369m-retail-entitlement-offer-opens 2024-06-18T19:15:51-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-a550m-us369m1-retail-entitlement-offer-opens 2024-06-18T20:57:58-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-5 2024-06-19T20:05:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-cleansing-statement 2024-06-20T18:31:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-90 2024-06-24T18:21:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-91 2024-06-25T02:40:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-publication-vegf-c-and-d-signaling-pathways 2024-07-09T07:30:57-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-publication-vegf-c-and-d 2024-07-09T18:33:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/security-class-suspension-quotation-optob 2024-07-11T12:21:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-results-retail-entitlement-a559m 2024-07-14T18:37:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-results-a559m-us369m1-retail-entitlement-offer 2024-07-14T21:47:20-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-6 2024-07-16T21:50:42-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optob-top-holders 2024-07-16T22:18:35-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optob-range-units 2024-07-16T22:18:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/security-class-reinstatement-quotation-optob 2024-07-17T05:10:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-welcomes-international-retina-thought-leaders-join-its 2024-07-17T07:15:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-welcomes-retina-leaders-its-medical-advisory-board 2024-07-17T18:29:02-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-92 2024-07-18T18:21:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-93 2024-07-19T03:15:42-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-0 2024-07-30T20:33:12-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/updated-quarterly-report-and-cashflow 2024-08-01T02:16:22-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-hc-wainwright-4th-annual-ophthalmology 2024-08-08T08:10:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-hc-wainwright-virtual-conference 2024-08-08T18:30:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-preliminary-final-and-annual-report 2024-08-30T04:27:19-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-2024-corporate-governance-statement 2024-08-30T04:36:16-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-full-year-results 2024-08-30T04:36:35-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-full-year-financial-results-and-business-updates 2024-08-30T07:30:31-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-hc-wainwright-26th-global-investment 2024-09-03T07:30:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-hcwainwright-26th-investment-conference 2024-09-03T18:30:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-executive-leadership-changes-senior-hires 2024-09-04T18:37:26-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-executive-leadership-changes-and-senior-hires 2024-09-05T13:34:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/sp-dji-announces-september-2024-quarterly-rebalance 2024-09-06T03:16:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-september-2024 2024-09-08T18:48:34-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-have-significant-presence-24k-euretina-congress-and 2024-09-10T07:30:46-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-presents-24th-euretina-congress 2024-09-10T18:33:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-completion-drug-substance-ppq-campaign 2024-09-18T07:30:41-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-completion-drug-substance-campaign 2024-09-18T18:20:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-joins-spasx-300-index 2024-09-22T18:43:49-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-joins-spasx-300-index-0 2024-09-23T07:00:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-euretina-symposium-2024 2024-09-26T05:15:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-ubs-virtual-ophthalmology-day-2024 2024-09-30T07:30:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-ubs-virtual-ophthalmology-day-2024-0 2024-09-30T18:22:35-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-35 2024-10-03T18:39:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-chief-medical-and-chief-financial-officer 2024-10-07T17:55:47-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-chief-medical-officer-and-chief-financial 2024-10-08T07:00:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-wet-amd-program-be-presented-innovate-retina 2024-10-09T17:52:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-wet-amd-program-be-presented-innovate-retina-0 2024-10-10T07:30:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meetingproxy-form-0 2024-10-15T19:11:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-files-notice-annual-general-meeting 2024-10-15T19:11:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-files-notice-annual-general-meeting-0 2024-10-16T07:00:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-corporate-presentation-oct-2024 2024-10-27T17:41:30-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-1 2024-10-30T17:59:24-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-november-investor-conferences 2024-11-03T16:30:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/update-opthea-participates-november-investor-conferences 2024-11-03T19:35:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-november-investor-conferences-0 2024-11-04T07:00:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-wet-amd-program-featured-ophthalmology-events 2024-11-11T16:45:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-wet-amd-program-featured-ophthalmology-events-0 2024-11-12T07:01:32-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/chairs-address-shareholders 2024-11-14T17:36:38-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/director-appointmentresignation-0 2024-11-14T17:44:14-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-received-a159-million-rd-tax-incentive 2024-11-14T18:25:39-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-meeting-11 2024-11-14T18:25:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/initial-directors-interest-notice-0 2024-11-14T21:04:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-appoints-kathy-connell-board-directors 2024-11-15T07:01:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-citi-2024-global-healthcare-conference 2024-11-24T17:50:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-participate-citi-2024-global-healthcare-conference-0 2024-11-25T07:00:38-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-wet-amd-program-be-featured-floretina-2024 2024-11-25T16:27:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-wet-amd-program-be-featured-floretina-2024-0 2024-11-26T07:00:41-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-17 2024-12-15T17:50:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-18 2024-12-15T18:00:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-19 2024-12-15T18:06:07-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-20 2024-12-15T18:40:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-ss 2024-12-16T16:28:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-so 2024-12-16T16:28:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-qo 2024-12-16T16:29:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-lg-1 2024-12-16T16:29:10-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-jh-0 2024-12-16T16:29:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-1 2024-12-16T16:29:36-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-jl-1 2024-12-16T16:29:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-43rd-jp-morgan-healthcare-conference 2024-12-18T16:40:31-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-43rd-annual-jp-morgan-healthcare-conference 2024-12-19T07:00:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-21 2024-12-23T21:35:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-cessation-securities-opt 2024-12-23T21:44:40-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-22 2024-12-23T21:45:19-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-7 2024-12-23T22:01:16-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-publication-diabetic-macular-edema 2025-01-06T16:27:36-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-publication-diabetic-macular-edema-0 2025-01-07T07:00:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-investor-days-new-york-and-australia 2025-01-07T17:20:50-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-host-investor-days-new-york-and-australia-0 2025-01-08T07:00:37-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/optheas-corporate-presentation-jan-2025 2025-01-13T16:25:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-investor-day 2025-01-28T16:16:21-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-8 2025-01-29T17:51:24-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-2 2025-01-30T18:46:48-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-94 2025-02-04T01:01:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-wet-amd-data-featured-macula-society-meeting 2025-02-05T17:15:57-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-wet-amd-data-featured-macula-society-meeting-0 2025-02-06T07:01:42-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-oppenheimer-healthcare-conference-0 2025-02-06T16:41:11-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-present-oppenheimer-healthcare-conference-1 2025-02-07T07:00:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-9 2025-02-11T02:56:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-cessation-securities-opt-0 2025-02-11T02:56:29-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-10 2025-02-17T00:15:59-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-coast-final-week-52-patient-visit 2025-02-17T16:28:51-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-coast-final-week-52-patient-visit-0 2025-02-18T07:00:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-11 2025-02-18T16:59:17-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-12 2025-02-21T00:56:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-12 2025-02-21T00:56:00-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-drug-product-ppq-campaign 2025-02-25T16:42:05-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-completes-drug-product-ppq-campaign-0 2025-02-26T07:00:56-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-half-year-results-and-business-updates 2025-02-27T16:48:48-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-half-year-financial-report-appendix-4d 2025-02-27T16:49:53-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-reports-half-year-results-and-business-updates-0 2025-02-28T07:01:28-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-phase-2b-wet-amd-publication 2025-03-02T16:34:46-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-phase-2b-wet-amd-publication-0 2025-03-03T07:01:20-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-13 2025-03-10T22:20:28-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-14 2025-03-10T22:20:38-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/update-application-quotation-securities-opt-0 2025-03-13T22:25:32-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-15 2025-03-14T01:16:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-15 2025-03-14T01:16:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-36 2025-03-14T04:31:24-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/trading-halt-9 2025-03-16T17:48:03-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/voluntary-suspension 2025-03-18T18:41:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-coast-phase-3-trial-topline-results 2025-03-24T00:01:21-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-coast-phase-3-trial-topline-results-0 2025-03-24T08:10:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-34 2025-03-24T17:22:35-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-37 2025-03-30T17:27:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/continuation-suspension-quotation 2025-03-30T21:45:43-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-decision-discontinue-wet-amd-trials 2025-03-30T21:46:03-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-decision-discontinue-wet-amd-trials-0 2025-03-31T00:01:30-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-provides-corporate-update 2025-04-09T19:29:16-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-3 2025-04-29T19:12:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-35 2025-05-11T18:17:44-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-provides-corporate-update-0 2025-06-01T18:45:39-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-quinton-oswald 2025-06-01T19:15:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-dr-susan-orr 2025-06-01T19:16:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-dr-julia-haller 2025-06-01T19:16:23-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/final-directors-interest-notice-anshul-thakral 2025-06-01T19:16:33-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/details-company-address 2025-07-03T23:20:57-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/long-term-suspended-entities 2025-07-16T02:22:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-4 2025-07-29T18:44:14-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-16 2025-08-08T04:05:29-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-provides-corporate-update-1 2025-08-18T18:51:15-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-provides-corporate-update-2 2025-08-18T20:27:56-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-17 2025-08-18T21:50:07-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/corporate-update-investor-call 2025-08-19T19:23:13-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/becoming-substantial-holder-38 2025-08-21T04:55:52-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/ceasing-be-substantial-holder-36 2025-08-21T18:23:30-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/preliminary-final-report-1 2025-08-29T05:21:41-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/application-quotation-securities-opt-18 2025-09-05T02:51:59-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/sp-dji-announces-september-2025-quarterly-rebalance 2025-09-05T03:10:36-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/2025-corporate-governance-statement 2025-09-15T01:18:05-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/annual-report-shareholders 2025-09-15T01:18:25-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-annual-general-meeting-date 2025-09-15T19:52:50-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-receives-a108-million-rd-tax-incentive 2025-10-05T17:42:26-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-annual-general-meetingproxy-form-1 2025-10-09T17:45:20-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appointment-company-secretary-and-cfo 2025-10-26T18:50:53-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/opthea-announces-intention-delist-nasdaq 2025-10-29T18:40:10-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-5 2025-10-30T19:11:17-04:00 0.5 https://ir.opthea.com/news-releases/news-release-details/results-agm 2025-11-10T19:20:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/voluntary-delisting-nasdaq-takes-effect 2025-11-20T17:26:34-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-substantial-holding-95 2025-12-07T16:21:38-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notice-market-update 2025-12-11T17:30:35-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/investor-update-presentation 2025-12-16T18:05:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-regarding-unquoted-securities-opt-23 2025-12-18T20:25:45-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/change-directors-interest-notice-kc-lg 2025-12-22T16:45:47-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/notification-cessation-securities-opt-1 2026-01-14T23:30:43-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/long-term-suspended-entities-0 2026-01-22T00:36:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/quarterly-activitiesappendix-4c-cash-flow-report-6 2026-01-29T17:40:30-05:00 0.5 https://ir.opthea.com/news-releases/news-release-details/appendix-4d-and-half-year-report-period-31-dec-2025 2026-03-01T16:28:05-05:00 0.5 https://ir.opthea.com/sec-filings/sec-filing/f-1/0001193125-20-253365 2020-09-24T16:11:15-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/drs/0000950123-20-007024 2020-09-25T00:14:43-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/drsa/0000950123-20-009475 2020-09-25T00:15:35-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/f-1a/0001193125-20-267263 2020-10-09T16:46:28-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/8-a12b/0001193125-20-269423 2020-10-14T17:26:08-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/f-1a/0001193125-20-269919 2020-10-15T09:57:05-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/effect/9999999995-20-002889 2020-10-19T06:04:22-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/424b4/0001193125-20-272098 2020-10-19T17:00:11-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-20-273263 2020-10-21T06:10:50-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-20-277442 2020-10-27T06:06:33-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13g/0001214659-20-009311 2020-11-12T06:09:26-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/corresp/0001193125-20-270233 2020-11-17T00:08:15-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/corresp/0001193125-20-270231 2020-11-17T00:08:24-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/upload/0000000000-20-009376 2020-11-17T00:08:35-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/corresp/0001193125-20-267268 2020-11-17T00:08:40-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/s-8/0001193125-20-307084 2020-12-01T16:21:32-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-20-319486 2020-12-17T06:11:13-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-011473 2021-01-19T16:19:43-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001214659-21-001485 2021-02-10T06:06:16-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13g/0001104659-21-024263 2021-02-16T16:53:32-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-045439 2021-02-17T06:06:40-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-049765 2021-02-22T06:12:43-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/424b3/0001193125-21-049769 2021-02-22T06:15:32-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-053272 2021-02-24T06:11:28-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-071485 2021-03-05T16:18:24-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-080347 2021-03-15T06:34:48-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-094455 2021-03-25T19:03:30-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-101165 2021-03-31T06:22:41-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-106877 2021-04-06T06:09:35-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-178913 2021-06-02T06:04:55-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-184606 2021-06-08T06:05:28-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-190053 2021-06-14T16:17:51-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-195621 2021-06-22T06:13:15-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-208022 2021-07-06T06:12:55-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-240470 2021-08-09T16:32:34-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-241823 2021-08-10T16:18:43-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/upload/0000000000-20-007494 2021-08-15T22:13:08-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-259832 2021-08-30T06:44:55-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-264585 2021-09-02T17:03:41-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-271575 2021-09-13T17:06:46-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-277378 2021-09-20T17:02:48-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-290969 2021-10-04T16:17:13-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-302329 2021-10-20T06:06:08-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-21-308120 2021-10-26T17:16:35-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/20-f/0001564590-21-052421 2021-10-28T06:15:42-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-000611 2022-01-03T16:13:16-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-001797 2022-01-04T16:56:15-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-016032 2022-01-24T16:12:15-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/f-3/0001193125-22-023730 2022-02-01T06:25:34-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-023930 2022-02-01T06:47:29-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-032867 2022-02-09T17:19:43-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-034402 2022-02-10T16:03:14-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-039220 2022-02-14T06:42:51-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001214659-22-002652 2022-02-14T16:33:59-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001104659-22-022828 2022-02-14T16:44:26-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/effect/9999999995-22-000509 2022-02-28T06:17:55-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-055623 2022-02-28T06:20:08-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-062987 2022-03-02T16:17:36-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-071956 2022-03-10T16:17:22-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/upload/0000000000-22-001481 2022-03-26T00:08:08-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/corresp/0001193125-22-049901 2022-03-26T00:08:13-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-090042 2022-03-30T17:23:22-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-015145 2022-04-22T06:18:05-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-015153 2022-04-22T07:03:09-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-015154 2022-04-22T07:03:10-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-016579 2022-04-29T06:27:11-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-017987 2022-05-05T06:21:51-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-019048 2022-05-10T06:15:33-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-019368 2022-05-11T06:14:23-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-220475 2022-08-15T06:47:25-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-230069 2022-08-25T16:35:19-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-231346 2022-08-26T18:13:47-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-233400 2022-08-30T07:10:00-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-251263 2022-09-26T16:17:30-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/20-f/0001564590-22-032651 2022-09-29T11:18:11-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001564590-22-034917 2022-10-24T06:09:59-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-282636 2022-11-10T16:27:26-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-22-286779 2022-11-16T16:20:10-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-22-026058 2022-12-06T06:08:45-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-22-026331 2022-12-12T06:07:25-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-000637 2023-01-11T06:08:15-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-001331 2023-01-30T06:10:12-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-001811 2023-02-06T06:08:55-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-002515 2023-02-13T06:13:02-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001104659-23-021483 2023-02-14T16:10:52-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001062993-23-003572 2023-02-15T06:57:27-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-003900 2023-02-23T06:11:10-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-006079 2023-03-06T06:10:29-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-006347 2023-03-07T06:05:24-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-015498 2023-04-28T08:47:50-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-018442 2023-05-08T06:09:57-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-022603 2023-05-17T06:12:37-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-024036 2023-05-25T06:09:08-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-026893 2023-06-08T06:09:18-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-032316 2023-07-10T06:13:08-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-032751 2023-07-13T06:08:59-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-033921 2023-07-24T06:08:00-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-034541 2023-07-26T06:08:16-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-036135 2023-08-01T06:10:57-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-23-219476 2023-08-24T06:18:07-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-23-221999 2023-08-28T06:18:38-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-23-225375 2023-08-31T06:17:23-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-046857 2023-09-07T06:10:35-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-050229 2023-09-28T06:15:27-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/20-f/0000950170-23-050230 2023-09-28T06:22:39-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-050914 2023-10-02T06:11:14-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-055780 2023-10-27T06:14:56-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-055781 2023-10-27T06:17:52-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-056112 2023-10-30T06:11:38-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-061466 2023-11-09T06:10:58-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-066891 2023-11-30T06:10:54-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-066893 2023-11-30T06:10:54-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-071275 2023-12-19T06:10:19-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-23-073126 2023-12-27T06:08:53-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-003756 2024-01-11T06:08:41-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-009602 2024-02-01T06:11:08-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-014920 2024-02-14T06:09:08-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001214659-24-002905 2024-02-14T16:19:11-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001104659-24-023737 2024-02-14T16:23:06-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-016761 2024-02-20T06:09:37-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-022360 2024-02-29T06:05:39-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-024332 2024-03-04T06:09:06-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-026844 2024-03-06T06:06:44-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-033139 2024-03-19T06:09:01-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-040648 2024-04-03T06:09:13-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-041337 2024-04-04T06:02:55-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-041967 2024-04-05T06:12:32-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-041959 2024-04-05T06:12:41-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-042732 2024-04-09T06:07:33-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-047882 2024-04-25T06:10:44-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-050171 2024-04-30T06:15:26-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-050815 2024-05-01T06:10:46-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-064873 2024-05-28T06:10:36-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-067643 2024-06-03T06:06:51-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-072239 2024-06-12T06:10:50-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-072204 2024-06-12T06:11:02-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-072227 2024-06-12T06:11:26-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-073232 2024-06-14T06:11:04-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-075265 2024-06-20T06:09:58-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001214659-24-011989 2024-07-03T19:18:43-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-082291 2024-07-09T06:06:56-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-083369 2024-07-15T06:16:14-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-084055 2024-07-17T06:07:36-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-093266 2024-08-08T06:32:09-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-102071 2024-08-30T06:35:10-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/20-f/0000950170-24-102094 2024-08-30T08:52:16-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-102542 2024-09-03T06:10:19-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-103698 2024-09-05T06:29:40-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-104530 2024-09-09T06:09:10-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-104906 2024-09-10T06:08:55-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-107588 2024-09-18T06:08:36-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/20-fa/0000950170-24-108246 2024-09-20T06:12:09-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-108611 2024-09-23T06:07:47-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-109462 2024-09-26T06:15:04-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-110160 2024-09-30T06:07:12-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-113398 2024-10-08T06:08:55-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-113944 2024-10-10T06:05:48-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-114834 2024-10-16T06:08:14-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-114835 2024-10-16T06:10:06-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-117543 2024-10-28T06:11:25-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-119782 2024-11-01T06:08:56-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-120255 2024-11-04T06:06:19-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-124459 2024-11-12T09:25:27-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/sc-13ga/0001214659-24-018905 2024-11-14T06:07:23-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-127381 2024-11-15T06:16:11-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-128267 2024-11-19T06:06:46-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-130414 2024-11-25T06:29:04-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-130745 2024-11-26T06:10:59-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-24-138204 2024-12-19T06:06:03-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-002545 2025-01-07T06:06:12-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-003203 2025-01-08T06:05:29-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-004506 2025-01-13T07:27:38-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-009607 2025-01-28T13:32:14-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-014953 2025-02-06T06:06:14-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-015830 2025-02-07T06:08:35-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-021780 2025-02-18T06:18:18-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-027304 2025-02-26T06:07:40-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-029489 2025-02-28T06:09:51-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-030353 2025-03-03T06:07:06-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-043476 2025-03-24T06:09:47-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-047169 2025-03-31T06:08:52-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-052661 2025-04-10T06:10:48-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-080006 2025-06-02T06:10:03-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-109921 2025-08-19T06:07:44-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-109928 2025-08-19T06:33:23-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0000950170-25-110268 2025-08-20T06:08:14-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-191693 2025-08-29T06:12:06-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-202677 2025-09-15T06:33:15-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/20-f/0001193125-25-202743 2025-09-15T06:57:44-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-230839 2025-10-06T06:09:31-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-236292 2025-10-10T06:05:49-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-250608 2025-10-27T06:06:09-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-257488 2025-10-30T08:07:56-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-259864 2025-10-31T09:33:00-04:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/25/0001193125-25-273377 2025-11-10T08:49:50-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/s-8-pos/0001193125-25-273380 2025-11-10T08:52:12-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-276112 2025-11-12T08:36:19-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/6-k/0001193125-25-289730 2025-11-20T16:05:39-05:00 0.4 https://ir.opthea.com/sec-filings/sec-filing/15f-12b/0001193125-25-289744 2025-11-20T16:06:28-05:00 0.4 https://ir.opthea.com/analyst 2024-04-01T15:57:59-04:00 0.5 https://ir.opthea.com/analyst/shane-storey-elyse-sharpio 2024-04-01T15:59:14-04:00 0.5 https://ir.opthea.com/nasdaq/yigal-nochomovitz 2023-03-03T08:44:30-05:00 0.5 https://ir.opthea.com/axs/rosemary-cummins 2023-01-30T10:26:52-05:00 0.5 https://ir.opthea.com/nasdaq/hartaj-singh 2023-01-30T10:29:49-05:00 0.5 https://ir.opthea.com/nasdaq/matthew-caufield 2023-01-30T10:31:17-05:00 0.5 https://ir.opthea.com/nasdaq/kelly-shi 2023-01-30T10:31:58-05:00 0.5 https://ir.opthea.com/sean-kim 2024-08-06T18:15:09-04:00 0.5 https://ir.opthea.com/asx/david-nayagam 2024-04-01T16:00:06-04:00 0.5 https://ir.opthea.com/asx/thomas-wakim 2024-08-06T18:16:33-04:00 0.5 https://ir.opthea.com/board-member/jeremy-levin 2025-02-14T10:54:06-05:00 0.5 https://ir.opthea.com/board-member/sujal-shah 2025-02-14T10:55:47-05:00 0.5 https://ir.opthea.com/board-member/julia-haller 2025-02-14T10:55:30-05:00 0.5 https://ir.opthea.com/board-member/lawrence-gozlan 2025-02-14T10:56:21-05:00 0.5 https://ir.opthea.com/board-member/susan-orr 2025-02-14T10:57:08-05:00 0.5 https://ir.opthea.com/board-member/quinton-oswald 2025-02-14T10:57:37-05:00 0.5 https://ir.opthea.com/board-member/anshul-thakral 2025-02-14T10:58:15-05:00 0.5 https://ir.opthea.com/board-member/fred-guerard 2025-02-14T11:00:40-05:00 0.5 https://ir.opthea.com/board-member/kathy-connell 2025-07-03T11:11:29-04:00 0.5